| . | TEVAR (N = 9) . | Open surgery (N = 14) . | P-value . |
|---|---|---|---|
| Age | 76 ± 9 | 64 ± 19 | 0.09 |
| Gender, male/female | 6/3 | 9/5 | 0.91 |
| Hypertension, n (%) | 5 (56) | 8 (57) | 0.94 |
| Hyperlipidaemia, n (%) | 0 (0) | 2 (14) | 0.24 |
| Diabetes, n (%) | 0 (0) | 0 (0) | |
| COPD, n (%) | 2 (22) | 1 (7) | 0.30 |
| Previous cardiac surgery, n (%) | 1 (11) | 1 (7) | 0.74 |
| Maximum diameter of aorta (mm) | 51.6 ± 11.1 | 43.9 ± 11.2 | 0.13 |
| With malperfusion, n (%) | 0 (0) | 3 (21) | 0.14 |
| Preoperative shock, n (%) | 2 (22) | 6 (43) | 0.31 |
| Preoperative CPR, n (%) | 1 (11) | 2 (14) | 0.83 |
| . | TEVAR (N = 9) . | Open surgery (N = 14) . | P-value . |
|---|---|---|---|
| Age | 76 ± 9 | 64 ± 19 | 0.09 |
| Gender, male/female | 6/3 | 9/5 | 0.91 |
| Hypertension, n (%) | 5 (56) | 8 (57) | 0.94 |
| Hyperlipidaemia, n (%) | 0 (0) | 2 (14) | 0.24 |
| Diabetes, n (%) | 0 (0) | 0 (0) | |
| COPD, n (%) | 2 (22) | 1 (7) | 0.30 |
| Previous cardiac surgery, n (%) | 1 (11) | 1 (7) | 0.74 |
| Maximum diameter of aorta (mm) | 51.6 ± 11.1 | 43.9 ± 11.2 | 0.13 |
| With malperfusion, n (%) | 0 (0) | 3 (21) | 0.14 |
| Preoperative shock, n (%) | 2 (22) | 6 (43) | 0.31 |
| Preoperative CPR, n (%) | 1 (11) | 2 (14) | 0.83 |
COPD: chronic obstructive pulmonary disease; CPR: cardiopulmonary resuscitation; TEVAR: thoracic endovascular aortic repair.
| . | TEVAR (N = 9) . | Open surgery (N = 14) . | P-value . |
|---|---|---|---|
| Age | 76 ± 9 | 64 ± 19 | 0.09 |
| Gender, male/female | 6/3 | 9/5 | 0.91 |
| Hypertension, n (%) | 5 (56) | 8 (57) | 0.94 |
| Hyperlipidaemia, n (%) | 0 (0) | 2 (14) | 0.24 |
| Diabetes, n (%) | 0 (0) | 0 (0) | |
| COPD, n (%) | 2 (22) | 1 (7) | 0.30 |
| Previous cardiac surgery, n (%) | 1 (11) | 1 (7) | 0.74 |
| Maximum diameter of aorta (mm) | 51.6 ± 11.1 | 43.9 ± 11.2 | 0.13 |
| With malperfusion, n (%) | 0 (0) | 3 (21) | 0.14 |
| Preoperative shock, n (%) | 2 (22) | 6 (43) | 0.31 |
| Preoperative CPR, n (%) | 1 (11) | 2 (14) | 0.83 |
| . | TEVAR (N = 9) . | Open surgery (N = 14) . | P-value . |
|---|---|---|---|
| Age | 76 ± 9 | 64 ± 19 | 0.09 |
| Gender, male/female | 6/3 | 9/5 | 0.91 |
| Hypertension, n (%) | 5 (56) | 8 (57) | 0.94 |
| Hyperlipidaemia, n (%) | 0 (0) | 2 (14) | 0.24 |
| Diabetes, n (%) | 0 (0) | 0 (0) | |
| COPD, n (%) | 2 (22) | 1 (7) | 0.30 |
| Previous cardiac surgery, n (%) | 1 (11) | 1 (7) | 0.74 |
| Maximum diameter of aorta (mm) | 51.6 ± 11.1 | 43.9 ± 11.2 | 0.13 |
| With malperfusion, n (%) | 0 (0) | 3 (21) | 0.14 |
| Preoperative shock, n (%) | 2 (22) | 6 (43) | 0.31 |
| Preoperative CPR, n (%) | 1 (11) | 2 (14) | 0.83 |
COPD: chronic obstructive pulmonary disease; CPR: cardiopulmonary resuscitation; TEVAR: thoracic endovascular aortic repair.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
